Standout Papers

Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recu... 2006 2026 2012 2019 517
  1. Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG (2006)
    Jacobus Pfisterer, Marie Plante et al. Journal of Clinical Oncology

Immediate Impact

5 from Science/Nature 55 standout
Sub-graph 1 of 14

Citing Papers

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
From discoveries in ageing research to therapeutics for healthy ageing
2019 StandoutNature
2 intermediate papers

Works of Justine Rochon being referenced

The Ariadne principles: how to handle multimorbidity in primary care consultations
2014
Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
2006 Standout

Author Peers

Author Last Decade Papers Cites
Justine Rochon 834 497 632 522 65 2.9k
Laure Wynants 580 225 647 265 66 3.3k
Eunice Chang 446 197 480 487 157 4.1k
D. Hole 264 330 542 918 42 2.9k
René dePont Christensen 398 173 385 669 98 2.3k
R. Otter 381 166 441 1184 58 2.6k
Jackie Bridges 714 1025 363 331 133 3.1k
Noel S. Weiss 361 159 698 627 79 4.3k
Wanda K. Nicholson 565 471 908 296 140 4.9k
Susan Dutton 189 165 993 641 126 3.3k
Clare Bankhead 217 829 309 1051 108 4.6k

All Works

Loading papers...

Rankless by CCL
2026